These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2929999)

  • 21. Intravenous lecithin-coated microcrystals of dantrolene are effective in the treatment of malignant hyperthermia: an investigation in rats, dogs, and swine.
    Karan SM; Lojeski EW; Haynes DH; Bina S; Wesche DL; Boedeker BH; Muldoon SM
    Anesth Analg; 1996 Apr; 82(4):796-802. PubMed ID: 8615500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of feed restriction on plasma dantrolene concentrations in horses.
    McKenzie EC; Garrett RL; Payton ME; Riehl JH; Firshman AM; Valberg SJ
    Equine Vet J Suppl; 2010 Nov; (38):613-7. PubMed ID: 21059069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral dantrolene.
    Allen GC
    Anaesthesia; 2004 Nov; 59(11):1139; author reply 1139-40. PubMed ID: 15479327
    [No Abstract]   [Full Text] [Related]  

  • 24. [Malignant hyperthermia - therapy results with dantrolene. A case report].
    Wagner W; Feldmann E
    Anasth Intensivther Notfallmed; 1983 Oct; 18(5):270-1. PubMed ID: 6660445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dantrolene in human malignant hyperthermia.
    Kolb ME; Horne ML; Martz R
    Anesthesiology; 1982 Apr; 56(4):254-62. PubMed ID: 7039419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Suspected case of postoperative malignant hyperthermia treated with dantrolene one week after neurosurgery].
    Itoh K; Nishibe S; Usuda Y; Kitamura A
    Masui; 2014 Oct; 63(10):1153-5. PubMed ID: 25693350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prophylaxis with dantrolene sodium in 2 patients with susceptibility to malignant hyperthermia].
    Navas E; Sánchez-Peña J; Gutiérrez-Crespo A
    Rev Esp Anestesiol Reanim; 1992; 39(5):309-11. PubMed ID: 1410753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous dantrolene in a patient with myasthenia gravis.
    Mora CT; Eisenkraft JB; Papatestas AE
    Anesthesiology; 1986 Mar; 64(3):371-3. PubMed ID: 3954134
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prophylactic use of oral dantrolene for spinal anesthesia in a patient with susceptible malignant hyperthermia].
    Shindoh M; Enomoto K; Tatekawa S; Yukioka H; Yoshimoto N; Fujimori M
    Masui; 1988 Jul; 37(7):861-7. PubMed ID: 3230633
    [No Abstract]   [Full Text] [Related]  

  • 30. [An attempt to reconcile differences of opinion in the field of malignant hyperthermia].
    Schulte-Sasse U; Eberlein HJ
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Dec; 26(8):464-7. PubMed ID: 1786307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-anaesthetic administration of dantrolene sodium to a patient at risk from malignant hyperthermia: case report.
    Free CW; Jaimon MP
    N Z Med J; 1978 Dec; 88(626):493-4. PubMed ID: 283330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dantrolene and malignant hyperthermia.
    Dolan PF
    Anesthesiology; 1982 Sep; 57(3):246-7. PubMed ID: 7114551
    [No Abstract]   [Full Text] [Related]  

  • 33. Prophylactic and therapeutic doses of dantrolene for malignant hyperthermia.
    Flewellen EH; Nelson TE
    Anesthesiology; 1984 Oct; 61(4):477. PubMed ID: 6486512
    [No Abstract]   [Full Text] [Related]  

  • 34. Dantrolene dose response in malignant hyperthermia-susceptible (MHS) swine: method to obtain prophylaxis and therapeusis.
    Flewellen EH; Nelson TE
    Anesthesiology; 1980 Apr; 52(4):303-8. PubMed ID: 7362049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prophylaxis of malignant hyperthermia by oral dantrolene sodium in swine.
    Harrison GG
    Br J Anaesth; 1977 Apr; 49(4):315-7. PubMed ID: 889645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Reasons for the persistent lethality of malignant hyperthermia and recommendations for its reduction].
    Schulte-Sasse U; Eberlein HJ
    Anaesthesiol Reanim; 1991; 16(3):202-7. PubMed ID: 1888426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controversies regarding the prophylactic use of dantrolene for malignant hyperthermia.
    Wingard DW
    Anesthesiology; 1983 May; 58(5):489-90. PubMed ID: 6838012
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinically significant muscle weakness induced by oral dantrolene sodium prophylaxis for malignant hyperthermia.
    Watson CB; Reierson N; Norfleet EA
    Anesthesiology; 1986 Sep; 65(3):312-4. PubMed ID: 3752576
    [No Abstract]   [Full Text] [Related]  

  • 39. Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia.
    Shafer A; Doze VA; Shafer SL; White PF
    Anesthesiology; 1988 Sep; 69(3):348-56. PubMed ID: 3261954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dantrolene in porcine malignant hyperthermia.
    Gronert GA; Milde JH; Theye RA
    Anesthesiology; 1976 Jun; 44(6):488-95. PubMed ID: 1275316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.